Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03803553
Title Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Massachusetts General Hospital

colon adenocarcinoma


Binimetinib + Cetuximab + Encorafenib


Fluorouracil + Irinotecan + Leucovorin

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from for the field